ArticleCells2021

Remdesivir and Ledipasvir among the FDA-Approved Antiviral Drugs Have Potential to Inhibit SARS-CoV-2 Replication.

Rameez Hassan Pirzada et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.